市場調查報告書
商品編碼
978900

胃腸藥的全球市場(2027年前的預測) - COVID-19的影響,醫藥品分類,給藥途徑,用途,流通管道,各地區的分析

Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class ; Route of Administration ; Application ; Distribution Channel, and Geography

出版日期: | 出版商: The Insight Partners | 英文 209 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球胃腸藥的市場規模在2019年估算為490億4,338萬美金。該市場在2020年∼2027年間預測將以4.9%的年複合成長率增長,2027年達到713億28萬美元。

本報告提供全球胃腸藥市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,COVID-19疫情的影響,藥物類別·給藥途徑·用途·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 要點

第3章 調查手法

第4章 市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 市場動態

  • 主要的成長因素
  • 市場阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 市場收益預測與分析
  • 各地區:預測與分析
  • 主要企業的市場地位

第7章 市場分析:各類藥物

  • 概要
  • 市場收益佔有率(2019,2027)
  • 酸中和劑
  • 止瀉藥·瀉藥
  • 抗發炎藥
  • 制吐劑
  • 生技藥品
  • 其他

第8章 市場分析:各給藥途徑

  • 概要
  • 市場佔有率(2019,2027)
  • 口服
  • 非口服

第9章 市場分析:各用途

  • 概要
  • 市場收益佔有率(2019,2027)
  • 發炎性潰瘍性大腸炎
  • 克隆氏症
  • 大腸激躁症
  • 腸胃炎
  • 麩質過敏症
  • 其他

第10章 市場分析:各流通管道

  • 概要
  • 市場佔有率(2019,2027)
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第11章 市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第12章 COVID-19疫情的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第13章 產業形勢

  • 概要
  • 市場企業的成長策略
  • 有機開發
  • 無機開發

第14章 企業簡介

  • Sanofi
  • GlaxoSmithKline plc.
  • Johnson and Johnson Services, Inc.
  • Bausch Health
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
  • AbbVie Inc.
  • Bayer AG
  • Celltrion Healthcare Co.,Ltd.
  • LEXICON PHARMACEUTICALS, INC

第15章 附錄

  • 詞彙表
目錄
Product Code: TIPRE00014758

The gastrointestinal drugs market was valued at US$ 49,043.38 million in 2019 and is projected to reach US$ 71,300.28 million by 2027; it is expected to grow at a CAGR of 4.9% from 2020 to 2027.

The growth of the gastrointestinal drugs market is mainly attributed to factors such as rise in prevalence of gastrointestinal (GI) diseasesand increase in development of biologics. However, the market is likely to get impacted by the low awareness associated with gastrointestinal disorders in low-income economiesduring the forecast period.

Increasing development of biologics for the treatment of GI diseases is driving the growth of the market . In the last few years, new treatments called biologics are being used for the treatment of inflammatory diseases. Currently, the FDA has approved Humira, Cimzia, Remicade, Simponi, Tysabri, and Entyvio biologics for the treatment of Crohn's disease and ulcerative colitis (UC). Biologics have revolutionized the IBD treatment, and their success in the treatment of these indications is driving the use of biologics in other GI conditions, such as celiac disease, eosinophilic esophagitis, and autoimmune hepatitis. The development of new medication is driving the growth of the market . For instance, in September 2019, Janssen Pharmaceutical received the European Commission approval for STELARA. It would be used in the treatment of moderately to severely active ulcerative colitis in adults. It is the first biologic treatment that would target the IL-12/IL-23 pathway, an important therapeutic target in UC. Apart from this, strategic initiatives by market players, such as product launch in untapped market s, are further driving the growth of the market . For instance, in July 2020, Takeda Pharmaceutical Company launched its blockbuster biologic drug Vedolizumab in India as part of its GI portfolio. Vedolizumab would be sold in India under the brand name Kynteles. It would be used for the treatment of chronic inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. The cases of GI disorders are on the rise in developing countries. For instance, there are currently around 1.5 million IBD patients in India. The introduction of new biologics in these market s is expected to drive the market growth during the forecast period.

Moreover, along with product launches, the market players are carrying out different strategies to add innovative therapies in their product portfolio. This is further driving the growth of the gastrointestinal drugs market . For instance, in February 2020, Takeda Pharmaceutical Company Limited acquired PvP Biologics, Inc. This acquisition added investigational medicine TAK-062 (Kuma062) in the company's GI portfolio, which would be used for the treatment of uncontrolled celiac disease. The company is planning to submit data from the Phase 1 study for presentation at an upcoming medical congress. Globally, many people are living with celiac disease, and they manage their symptoms by following a gluten-free diet. There is still no treatment for people who experience severe symptoms. With this acquisition, the company is expecting to bring new therapies in the area of celiac disease management.

Drug Class-Based Insights

Based on drug class, the gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others. In 2019, the acid neutralizers segment accounted for the highest share of the market . Growth of this segment is attributed to increasing incidence of GERD and rising patient pool across the globe. However, the biologics segment is likely to register highest CAGR in the global gastrointestinal drugs market during the forecast period.

Route of Administration-Based Insights

In terms of route of administration, the gastrointestinal drugs market is segmented into oral and parenteral. The oral segment held the largest share of the market in 2019, whereas the same segment is expected to register the highest CAGR of 5.2% in the market during the forecast period.

Application-Based Insights

Based on application, the gastrointestinal drugs market is categorized into inflammatory ulcerative colitis, Crohn's disease, irritable bowel syndrome, gastroenteritis, celiac disease, and others. The inflammatory ulcerative colitis segment held the largest share of the market in 2019, whereas the irritable bowel syndrome segment is estimated to register the highest CAGR of 5.8% during the forecast period.

Distribution Channel-Based Insights

In terms of distribution channel, the gastrointestinal drugs market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment held the largest share of the market in 2019, and same segment is projected to register the highest CAGR of 5.4% in the market during the forecast period.

National Health Interview Survey, Guts Charity organization, National Center for Biotechnology Information, ClinicalTrials.gov., European Federation of Crohn's & Ulcerative Colitis Associations, Centers for Disease Control and Prevention, International Foundation for Gastrointestinal Disorders, Crohn's & Colitis Foundation of America, American College of Gastroenterology, American Academy of Family Physicians, National Institutes of Health, Celiac Disease Foundation, International Trade Administration, InterAmerican Heart Foundation (FIC), Colombian Association of Integral Medicine Companies (ACEMI), are some of the major primary and secondary sources referred to whilepreparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastrointestinal drugs market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Gastrointestinal Drugs Market - By Drug Class
    • 1.3.2 Gastrointestinal Drugs Market - By Route of Administration
    • 1.3.3 Gastrointestinal Drugs Market - By Application
    • 1.3.4 Gastrointestinal Drugs Market - By Distribution Channel
    • 1.3.5 Global Gastrointestinal Drugs Market - By Geography

2. Gastrointestinal Drugs Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Gastrointestinal Drugs- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Gastrointestinal Drugs Market- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
    • 5.1.2 Increase in Development of Biologics
  • 5.2 Market Restraints
    • 5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
  • 5.4 Future Trends
    • 5.4.1 Emergence of Biosimilars
  • 5.5 Impact Analysis

6. Gastrointestinal Drugs Market - Global Analysis

  • 6.1 Global Gastrointestinal Drugs Marker Revenue Forecast And Analysis
  • 6.2 Global Gastrointestinal Drugs Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Gastrointestinal Drugs Market Analysis - By Drug Class

  • 7.1 Overview
  • 7.2 Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)
  • 7.3 Acid Neutralizers
    • 7.3.1 Overview
    • 7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Antidiarrheal and Laxatives
    • 7.4.1 Overview
    • 7.4.2 Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Anti-Inflammatory Drugs
    • 7.5.1 Overview
    • 7.5.2 Anti-Inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Antiemetic and Antinauseants
    • 7.6.1 Overview
    • 7.6.2 Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Biologics
    • 7.7.1 Overview
    • 7.7.2 Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

8. Gastrointestinal Drugs Market Analysis - By Route of Administration

  • 8.1 Overview
  • 8.2 Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027
  • 8.3 Oral
    • 8.3.1 Overview
    • 8.3.2 Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Parenteral
    • 8.4.1 Overview
    • 8.4.2 Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

9. Gastrointestinal Drugs Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)
  • 9.3 Inflammatory Ulcerative Colitis
    • 9.3.1 Overview
    • 9.3.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Crohn's Disease
    • 9.4.1 Overview
    • 9.4.2 Crohn's Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Irritable Bowel Syndrome
    • 9.5.1 Overview
    • 9.5.2 Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Gastroenteritis
    • 9.6.1 Overview
    • 9.6.2 Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Celiac Disease
    • 9.7.1 Overview
    • 9.7.2 Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

10. Gastrointestinal Drugs Market Analysis - By Distribution Channel

  • 10.1 Overview
  • 10.2 Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027
  • 10.3 Hospital Pharmacies
    • 10.3.1 Overview
    • 10.3.2 Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Retail Pharmacies
    • 10.4.1 Overview
    • 10.4.2 Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.5 Online Pharmacies
    • 10.5.1 Overview
    • 10.5.2 Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

11. Gastrointestinal Drugs Market Analysis And Forecast To 2027 - Geographical Analysis

  • 11.1 North America: Gastrointestinal Drugs Market
    • 11.1.1 Overview
    • 11.1.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 11.1.3 North America: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
    • 11.1.4 North America: Gastrointestinal Drugs Market, by Route of Administration, 2018-2027 (USD Million)
    • 11.1.5 North America: Gastrointestinal Drugs Market, by Application, 2018-2027 (USD Million)
    • 11.1.6 North America: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.1.7 North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
    • 11.1.8 US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.1 US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.2 US: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.1.8.3 US: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.1.8.4 US: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.1.8.5 US: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.1.9 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.1 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.2 Canada: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.1.9.3 Canada: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.1.9.4 Canada: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.1.9.5 Canada: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.1.10 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.1 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.2 Mexico: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.1.10.3 Mexico: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.1.10.4 Mexico: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.1.10.5 Mexico: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.2 Europe: Gastrointestinal Drugs Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 11.2.3 Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
    • 11.2.4 Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
    • 11.2.5 Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
    • 11.2.6 Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.7 Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
    • 11.2.8 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.1 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.2 Germany: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.2.8.3 Germany: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.2.8.4 Germany: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.2.8.5 Germany: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.9 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.1 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.2 UK: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.2.9.3 UK: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.2.9.4 UK: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.2.9.5 UK: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.10 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.1 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.2 France: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.2.10.3 France: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.2.10.4 France: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.2.10.5 France: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.11 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.1 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.2 Spain: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.2.11.3 Spain: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.2.11.4 Spain: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.2.11.5 Spain: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.12 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.1 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.2 Italy: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.2.12.3 Italy: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.2.12.4 Italy: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.2.12.5 Italy: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.13 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.13.1 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.13.2 Rest of Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.2.13.3 Rest of Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.2.13.4 Rest of Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.2.13.5 Rest of Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.3 Asia Pacific: Gastrointestinal Drugs Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 11.3.3 Asia Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
    • 11.3.4 Asia Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
    • 11.3.5 Asia Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
    • 11.3.6 Asia Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.7 Asia Pacific: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
    • 11.3.8 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.1 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.2 China: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.3.8.3 China: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.3.8.4 China: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.3.8.5 China: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.9 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.1 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.2 Japan: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.3.9.3 Japan: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.3.9.4 Japan: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.3.9.5 Japan: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.10 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.1 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.2 India: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.3.10.3 India: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.3.10.4 India: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.3.10.5 India: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.11 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.1 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.2 South Korea: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.3.11.3 South Korea: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.3.11.4 South Korea: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.3.11.5 South Korea: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.12 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.1 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.2 Australia: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.3.12.3 Australia: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.3.12.4 Australia: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.3.12.5 Australia: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.13 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.13.1 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.13.2 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
      • 11.3.13.3 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
      • 11.3.13.4 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
      • 11.3.13.5 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.4 Middle East & Africa: Gastrointestinal Drugs Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
      • 11.4.2.1 Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 11.4.2.2 Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.4.2.3 Middle East & Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.4.2.4 Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.4.3 Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
      • 11.4.3.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
        • 11.4.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.2 Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.3 Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.4 Saudi Arabia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.5 Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.6 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
        • 11.4.3.6.1 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.7 UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.8 UAE Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.9 UAE Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.4.3.10 UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 11.5 South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
    • 11.5.1 South Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)
      • 11.5.1.1 South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 11.5.1.2 South Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.5.1.3 South Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.5.1.4 South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 11.6 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
    • 11.6.1 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)
      • 11.6.1.1 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
      • 11.6.1.2 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.6.1.3 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.6.1.4 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 11.7 South and Central America: Gastrointestinal Drugs Market
    • 11.7.1 Overview
    • 11.7.2 South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 11.7.3 South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
    • 11.7.4 South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 11.7.5 South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 11.7.6 South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.7.7 South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
    • 11.7.8 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.7.8.1 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.7.8.2 Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
      • 11.7.8.3 Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.7.8.4 Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.7.8.5 Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.7.9 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.7.9.1 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.7.9.2 Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
      • 11.7.9.3 Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.7.9.4 Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.7.9.5 Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 11.7.10 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.7.10.1 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 11.7.10.2 Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
      • 11.7.10.3 Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.7.10.4 Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.7.10.5 Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

12. Impact of COVID-19 Pandemic on Global Gastrointestinal Drugs Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Gastrointestinal Drugs Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Sanofi
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 GlaxoSmithKline plc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson and Johnson Services, Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Bausch Health
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 AstraZeneca
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Takeda Pharmaceutical Company Limited
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 AbbVie Inc.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Bayer AG
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Celltrion Healthcare Co.,Ltd.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 LEXICON PHARMACEUTICALS, INC
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary of Terms

List Of Tables

  • Table 1. North America Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe Gastrointestinal Drugs Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Germany Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Germany Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Germany Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 24. Germany Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 25. UK Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 26. UK Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 27. UK Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 28. UK Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 29. France Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 30. France Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 31. France Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 32. France Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Spain Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Spain Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Spain Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 36. Spain Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Italy Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Italy Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Italy Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 40. Italy Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Rest of Europe Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Rest of Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Rest of Europe Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 44. Rest of Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Asia Pacific Gastrointestinal Drugs Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
  • Table 46. Asia Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Asia Pacific Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 48. Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 49. China Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 50. China Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 51. China Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 52. China Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Japan Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Japan Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Japan Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 56. Japan Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 57. India Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 58. India Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 59. India Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 60. India Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South Korea Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South Korea Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South Korea Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 64. South Korea Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Australia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Australia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Australia Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 68. Australia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 72. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 73. Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 74. Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
  • Table 75. Middle East & Africa Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 76. Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
  • Table 79. Saudi Arabia Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 80. Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 81. UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 82. UAE Gastrointestinal Drugs Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
  • Table 83. UAE Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 84. UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 85. South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 86. South Africa Gastrointestinal Drugs Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
  • Table 87. South Africa Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 88. South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 89. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
  • Table 91. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 92. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 93. South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 94. South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 95. South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 96. South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 97. Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
  • Table 98. Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 99. Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 100. Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 101. Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
  • Table 102. Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 103. Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 104. Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 105. Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
  • Table 106. Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 107. Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 108. Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 109. Organic Developments Done By Companies
  • Table 110. Inorganic Developments Done By Companies
  • Table 112. Glossary of Terms, Gastrointestinal Drugs Market

List Of Figures

  • Figure 1. Gastrointestinal Drugs Market Segmentation
  • Figure 2. Gastrointestinal Drugs Market - By Geography
  • Figure 3. Gastrointestinal Drugs Market Overview
  • Figure 4. Acid Neutralizers Segment Held Largest Share of Gastrointestinal Drugs Market
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Gastrointestinal Drugs Market, by Geography (US$ Million)
  • Figure 7. Global Gastrointestinal Drugs Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Gastrointestinal Drugs Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
  • Figure 15. Global Gastrointestinal Drugs Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Gastrointestinal Drugs Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Gastrointestinal Drugs Market
  • Figure 18. Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)
  • Figure 19. Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Anti-Inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027
  • Figure 26. Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)
  • Figure 29. Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Crohn's Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 35. Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027
  • Figure 36. Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 37. Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 38. Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 39. North America: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 40. North America Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 41. North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 42. US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Europe: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. Europe Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
  • Figure 48. Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Asia Pacific: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 55. Asia Pacific Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 56. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. Middle East & Africa: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 63. Middle East & Africa Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 64. Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 65. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. South Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 68. Rest of Middle East and Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 69. South and Central America: Gastrointestinal Drugs Market , by Key Country - Revenue (2019) (USD Million)
  • Figure 70. South and Central America: Gastrointestinal Drugs Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 71. South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 72. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 73. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 74. Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 75. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in North American Countries
  • Figure 76. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in European Countries
  • Figure 77. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Asia Pacific Countries
  • Figure 78. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Rest of the World
  • Figure 79. Growth Strategies Done by the Companies in the Market, (%)